NEW YORK (GenomeWeb) – Oncologist group Valley Medical Oncology Consultants and Caris Life Sciences will establish a clinical molecular profiling program to serve cancer patients in the San Francisco Bay Area, they announced today.

The collaboration will use Caris Molecular Intelligence, a tumor profiling service to identify target therapies for patients based on their unique cancer biology. The service integrates molecular data generated from a patient's tumor into a report that includes biomarkers that are associated with therapies and/or available clinical trials.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.

A National Science Foundation-funded project aims to give researchers access to a network many times faster than the Internet.

Bioethicists weigh the idea of charging patients to take part in clinical research, coming down against the approach.

Cornell's Christopher Mason and his colleagues correct their New York City microbiome study to emphasize "the difference between matching fragments of DNA from a species and a pathogen."